The vast amount of heterogeneous omics data, encompassing a broad range of biomolecular information, requires novel methods of analysis, including those that integrate the available levels of information. In this work we describe Regression2Net, a computational approach that is able to integrate gene expression and genomic or methylome data in two steps. First, penalized regressions are used to build ExpressionExpression (EEnet) and Expression-Genome or -Methylome (EMnet) networks. Second, network theory is used to highlight important communities of genes. When applying our approach Regression2Net to gene expression and methylation profiles for individuals with glioblastoma multiforme, we identified respectively 284 and 447 potentially interesting genes in relation to glioblastoma pathology. These genes showed at least one connection in the integrated networks ANDnet and XORnet derived from aforementioned EEnet and EMnet networks. Whereas the edges in ANDnet occur in both EEnet and EMnet, the edges in XORnet occur in EMnet but not in EEnet. In-depth biological analysis of connected genes in ANDnet and XORnet revealed genes that are related to energy metabolism, cell cycle control (AATF), immune system response and several cancer types. Importantly, we observed significant over-representation of cancer related pathways including glioma, especially in the XORnet network, suggesting a non-ignorable role of methylation in glioblastoma multiforma. In the ANDnet, we furthermore identified potential glioma suppressor genes ACCN3 and ACCN4 linked to the NBPF1 neuroblastoma breakpoint family, as well as numerous ABC transporter genes (ABCA1, ABCB1) suggesting drug resistance of glioblastoma tumors.
Introduction
Glioblastomas are aggressive brain tumors affecting glial cells of the central nervous system including astrocytes and oligodendrocytes. The exact causes are not fully understood but current experimental evidence suggests that its onset is linked to mutations in the p53 gene, the essential cell cycle control protein and neurofibromin 1 -NF1, inhibitor of the RAS signaling pathway (ZHU et al. 2005) . In oligodendrocyte tumors the key marker OLIG2 that regulates oligodendrocyte differentiation, is not expressed (MARIE et al. 2001) . Additional studies confirm that the key markers of glial cancers are related to nerve cell development BMP-BMPR/RAS-APK and PI3K-activated signaling pathways. The genetic inheritance component of glioblastomas is thought to be weak based on heterogeneity of genetic alternations of known disease markers amongst subjects (KRAUS et al. 2001) . This heterogeneity enormously complicates the development of effective therapies. However, exploiting the availability of high-throughput omics data, together with the development of novel computational data integrative analysis techniques, may facilitate formulating targeted biological and clinical hypotheses. These hypotheses potentially speed up research and improve early detection and diagnosis of glioblastomas in clinical settings.
Several authors have indicated the added value of integrative omics analysis that involve the integration of at least two different omics data types, referring to different biological components in a cell. The methodologies to analyze such data are starting to emerge, with the biggest success stories reported for 2-omics analyses. Examples of 2-omics analyses include eQTL (FRANKE and JANSEN 2009) and meQTL (SMITH et al. 2014) analyses that respectively assess the influence of genetic and epigenetic markers on gene expression. Combining >2 omics data types is much more complex, given the hierarchical structure and interdependencies such data entails (HAMID et al. 2009 ; VAN STEEN and MALATS 2014; RITCHIE et al. 2015) . With a few exceptions, most methods integrate >2 different data sources by combining evidences obtained from pairwise analyses ( VAN STEEN and MALATS 2014) . These evidences are often based on the derivation of standard measures of association, linking (epi-)genetic markers to gene expression combined with gene expression analysis (WAGNER et al. 2014) .
In this work, we developed a novel integration pipeline, Regression2Net, which combines information from for instance methylation and gene expression data via penalized regressions to construct gene-based networks. We furthermore applied our method to publicly available data for individuals affected by glioblastoma multiforme. The original glioblastoma pre-processed and partially annotated data were obtained from (WANG et al. 2014 ) (see online supplementary). By comparing the topology of the integrated networks derived from the inferred Expression-Expression and Expression-Methylation networks, and via subsequent functional analysis, we identified a list of genes with potential interest to the trait under consideration. In addition, our approach was capable of discovering biological mechanisms that may further enhance our understanding about the disease. Although experimental verification is needed to validate the novel formulated hypotheses in this work, our approach highlighted pathways that are significantly associated to glioblastoma. This suggests that our approach is one step forward towards translating evidences from bench to bedside. In the next section, we motivate and provide details about the proposed integrative analysis pipeline Regression2Net.
Method
Regression2Net uses a combination of penalized regression analysis and network theory to find structure in multiple omics data. The main goal of Regression2Net consists of inferring gene network topologies and deriving meaningful key communities of disease-associated genes based on integrated data. To facilitate the explanation of our approach, we assume having transcriptome and epigenome data, collected on the same set of individuals. We split the entire analytic pipeline in four parts, which we describe below.
Part 1: Penalized regression
Here, we consider each gene as response and regress it (via penalized regression) against the remaining genes. Since both gene expression and methylation data may contribute to a gene's expression level, we perform two types of regression: one in which only gene expression data are used, and one in which gene expression data (e.g., via gene expression probes) are used at the response level and methylation data (e.g., via methylation probes) as potential explanatory information. Thus the envisaged regressions consecutively consider each gene's expression as a dependent variable (response) and remaining gene expressions or methylation data as independent variables. Mapping of probes to genes is based on genomic location of the probe to the nearest gene as in (WANG et al. 2014) . The strategy for variable selection and their "significance" assessment with penalized regression is based on principles outlined in (MEINSHAUSEN and BÜHLMANN 2006) and was evaluated to synthetic data in (GADALETA and . In practice, One important feature of the L1-norm penalty is a tendency to shrink many coefficients to zero and to consequently remove them from the set of predictors X. This is an effective way to provide sparse solutions, which in turns lowers the variance of the selected regression coefficients. Variance that is lower than the one provided by non-penalized regression approaches is usually associated to higher bias of the prediction, as explained in (TIBSHIRANI 1996) . However, since our goal is to perform variable selection, we do not consider higher bias as a harmful limitation. It would be so if we were interested in predicting the expression value of the response genes. It is known that the crucial parameter that directly determines the rate of false positives and false negatives is the shrinkage factor λ in Equation 1. Regardless of a number of methods specifically designed to estimate λ reported in (EFRON et al. 2004; ZOU 2006; HIROSE et al. 2013 ), we perform 10-fold cross validation on a subset of the dataset, which provides an optimal estimate of the shrinkage factor. At the end of the iterative procedure, two collections of genes (corresponding to the two types of regressions) with their "explanatory genes" are obtained.
Part 2: Network construction
All explanatory genes are subsequently connected to the genes they explain. In practice, all aforementioned connections are stored within an adjacency matrix A, the entries of which (Aij) being binary values 0/1 that show if gene i and gene j are connected or not. This gives rise to two networks EEnet (ExpressionExpression network) and EMnet (Expression-Methylation network) respectively only using gene expression data and using both methylation and gene expression information. Note that for instance the number of methylation probes associated to a given gene may vary from one gene to another and hence multiple methylation probes may be considered as explanatory variables in the regression framework. The same holds for gene expression data where a single gene may be represented by multiple probes. Currently multiplicity is not explicitly accounted for in our strategy: In the presence of multiple probes per gene, two genes are connected in an EMnet (EEnet) network when there is evidence for it via at least one probe-pair.
Part 3: Identification of important genes
Here, the aim is to employ network-theory concepts to select the most important genes from the derived networks. These networks can be analyzed separately and results compared, or they can be integrated into a single combined network prior to analysis. A fundamental concept that needs to be clarified is the concept of "node importance". A simple procedure to select the most important nodes (or in this case genes) from a network is to consider its degree distribution. Note that the node degree or betweenness centrality of a specific node in a network is a local topological measure that refers to the number of connections the node has in the network. These local topological network descriptions can be summarized into a global description of the network via the degree distribution P(k). This distribution gives the proportion of nodes in the network having degree k. Node prioritization may then be based on selection of nodes in the EEnet and EMnet networks that have the highest degree. Biological networks are known to have negative (dissociative) degree correlation. Notably, two nodes with extremely high degrees are much less likely to be connected to each other than two nodes with low or zero degree (HAO and LI 2011) . This leads to formation of highly connected modules (e.g., hubs). However, there is no guarantee that an edge exists between two low degree nodes. we prioritize those genes with node degree ≥1, giving rise to three lists of unique genes. Those genes are then submitted to the last part of our integrative analysis pipeline.
Part 4: Annotation protocol and pathway enrichment analysis
In order to assess the significance of the selected genes in Part 3 in relation to the disease of interest, we perform annotation and pathway enrichment analyses, supplemented by literature searches. In practice, we use the R package biomaRt (R version 2.20.0) to annotate genes from gene expression data and the R packages GGHumanMethCancerPanelv1.db to annotate genes from methylation panels. 
Data
The data at our disposal are heterogeneous datasets composed of gene expression and methylation profiles of 215 individuals affected by glioblastoma already considered in a study of patient similarity in. DNA methylation probes (in total 1305) and mRNA (in total 12042) probes covered 680 and 12,042 genes, respectively. For more details about the platforms that generated the data, we refer to (WANG et al. 2014) .
Results

Data and network characteristics
The number of methylation probes associated to a given gene ranged between 0 and 4 (see Supplementary 
Annotation of the ANDnet and XORnet unique gene lists
The aforementioned 284 and 447 unique gene lists were annotated to biological functions and pathways in order to provide biological context in relation to glioblastoma pathology. Supplementary Tables S1 and S2 contain the complete list of gene annotations. The selected annotation criteria include gene name, chromosome name, ensemble gene and transcript IDs (see Supplementary Tables S1 and S2 ).
Amongst the 284 ANDnet genes are the two Amiloride-Sensitive Brain Sodium Channels encoded by ACCN3 and ACCN4 (Table S1 ). These genes were shown to be linked to the neuroblastoma breakpoint family NBPF1 genes related to the development of glioblastoma (VANDEPOELE et al. 2008) . The NBPF1 genes are thought to be involved in brain development and the neuroblastoma onset (JANOUEIX-LEROSEY et al. 2010) . When looking for the presence of transcription factors (TFs) amongst the genes of the ANDnet network, we noticed AATF and ABT1. They play an important role in the context of glioblastoma due to the fact that gene AATF controls crucial apoptotic cell death processes and gene ABT1 is responsible for basal transcription control via interaction with class II promoter sequences and onset of schizophrenia (SHI et al.
2009; GEJMAN et al. 2010). Genes belonging to the ATP-binding cassette (ABC) are numerous in the
ANDnet network. These transporter proteins are often involved in drug resistance (LAGE 2003) . Their strong presence amongst ANDnet genes suggests a complex gene regulatory mechanism that involves synergetic methylation and expression components. The complex regulation of the ABC genes has been confirmed in (VANDEPOELE et al. 2008) . Overall, the ANDnet network is mainly composed of genes related to energy metabolism, while the XORnet network is formed by genes related to various cancer types pathways, cell cycle control and immune system responses (Table S2) .
Enrichment analysis
The results of the KEGG pathway enrichment analyses are reported in Table 1 (Table 1) . The following genes, exclusively present in the XORnet, are linked to KEGG:hsa05200: AXIN1 -axin 1, FGF7 -fibroblast growth factor 7, FZD9 -frizzled class receptor 9, NKX3-1 -NK3 homeobox 1, and TGFB1 transforming growth factor, beta 1.
The relevance of some genes belonging to this pathway is supported by literature, specifically regarding gene NKX3-1, which is known to be implicated in prostate cancer development in adult mice (ABDULKADIR et al. 2002) , and gene FGF7, implicated in brain tumors (FRANCAVILLA et al. 2007 ).
In addition, the pathways identified in INTnet are most similar to those identified in XORnet. Common pathways relate to cancer (KEGG:hsa05200) and glioma (KEGG:hsa05214).
Discussion
The concept of a network makes it easy to visualize highly connected genes as potential regulators of biological activity. It also facilitates the detection of biological pathways under which those genes operate.
The fact that genes act depending on other genes and not as singletons is a well-accepted hypothesis in the biology community (HORVATH and DONG 2008; HUANG et al. 2008) . Generally speaking, a network model is composed of nodes and edges. In our specific application, each node represented a gene. Two genes were connected by an unweighted edge to indicate conditional dependence between them. If the edge between two genes does not exist, these two genes are considered to be conditionally independent. It has been shown that in gene co-expression networks, the degree of a gene or betweenness centrality of a specific node in the network is a good indicator of the gene's biological importance (AZUAJE 2014). Equally, it has been found that highly connected genes are responsible of fundamental biological functions and are potentially involved in many biological processes (HUANG et al. 2008; AZUAJE 2014) . Furthermore, biological networks often show sparse topology that usually resembles the structure of a power law network (BARABÁSI et al. 2011; SILVERMAN and LOSCALZO 2012) , also referred to as scale-free networks. For such networks, the distribution of the nodes degree follows a power law: whereas nodes with small degree are common, highdegree nodes with degrees far above the average node degree (hubs) are not. Hence, at first sight, the degree distribution offers an easy way to identify key nodes in the networks. However, there are reported cases of real biological networks in which node degrees show correlation patterns (i.e., the probability that two nodes are connected depends on their degrees dictated by network topology) (MASLOV and SNEPPEN 2002) .
Hence, the structure of a network is determined by the correlation pattern of node degrees (HAO and LI 2011), which may be hard to estimate accurately in networks of finite size (BOCCALETTI et al. 2006) .
Moreover, degree correlation patterns may differ between biological networks, hereby biasing making direct comparisons between networks and motivating going beyond degree correlation to highlight important drivers of topological structure.
Therefore, we combined EEnet and EMnet into integrated networks: either ANDnet, XORnet or INTnet. The motivation to derive XOR type of networks is our belief that expression-based gene-gene interactions may be quite different from gene-gene interactions that capture the effect of methylation on gene expression.
INTnet provides a more elaborate way of integrating EEnet and EMnet information based on the non-linear combination method of (WANG et al. 2014) . In our application, the INTnet approach gave rise to the same adjacency matrix as we would obtain by connecting two genes whenever a connection was present in the EEnet or in the EMnet (results not shown). Therefore, it is not surprising that the unique gene list derived from INTnet was larger than the gene sets derived from ANDnet or XORnet. Interestingly, the highest number of significantly enriched pathways was identified for XORnet (Table 1) , indicating the potential importance of methylation regulation in glioblastoma. Notably, whatever integrative network approach is followed, the quality of the integrated network will depend on the quality of the constituent networks. The
EEnet and EMnet networks may be differentially affected by false positive (or false negative) node connections due to technical and probe-selection biases related to the platform technologies that generated the data, hereby challenging signal over noise detections . The practical application included in this work relied on adequately cleaning and pre-processing the input data (WANG et al. 2014) .
Currently, in Regression2Net, mapping results for methylation probes to genes does not account for gene length, neither for the number of (methylation / transcription) probes in a gene. In our application, multiplicity only occurred in methylation data. In the presence of multiple methylation probes per gene, two genes are connected in the EMnet network when at least one methylation probe has been selected by penalized regression. We consider this an acceptable strategy due to the fact that the mapped ExpressionMethylation network of interest in our strategy is an unweighted one. Potentially, larger genes may have increased chances to get connected in a network, as those genes include a higher number of methylation probes. Investigation this in more depth is the subject of future research. Regardless, although there are more elaborate ways to deal with gene length and probe multiplicity, the integration pipeline applied to reallife data on glioblastoma produced biologically relevant results with good correspondence to evidences obtained from literature searches.
From a functional perspective NCAM (neural cell adhesion molecule) and FGF7 (fibroblast growth factor 7) in XORnet draw the attention. FGF competes with NCAM for FGF receptor binding (FGFR) that results in alteration of FGFR signalling (FRANCAVILLA et al. 2007) . Aberration in the expression levels of gene NCAM and excessive FGFR signalling have been shown to be correlated with tumor onset (VAWTER 2000; GROSE and DICKSON 2005) . In addition, among the XORnet genes we highlight the transcription factors FOSL2 and SIN3B in XORnet, which are respectively involved in cell proliferation and other oncogenic activities (see Table S2 ). More generally, XORnet was linked to 38 KEGG pathways, 10 of which are cancerrelated (Table 1) . We have shown that there is an added value in constructing and functionally analyzing both XORnet and ANDnet networks, since they may give complementary information. The genes of the ANDnet showed significant enrichment in 9 KEGG pathways. Of these 3 pathways are cancer-related: ABCtransporters (KEGG: hsa02010) (FLETCHER et al. 2010) , pathways in cancer (KEGG:hsa05200), hematopoietic cell lineage (KEGG:hsa 04640) (ZHAO et al. 2014 ).
Importantly, a total of 25 out of 284 genes (9%) of the ANDnet network and 79 out of 447 genes (18%) of the XORnet network could be linked to the KEGG metabolic pathways in cancer (KEGG:hsa05200). We consider this to be a significant result as it suggests that glioblastoma cancers seem to be strongly linked to the methylation component, which in turn perturbs the expression component (MCLENDON et al. 2008) . This is directly reflected within the topology of the EEnet and EMnet networks. Enrichment analysis of the 447 genes of the XORnet network (genes with degree ≥1) showed consistent presence of pathways related to cancer and biological processes including various types of carcinomas, cell signalling and immune system responses. This supports evidence that cancers have a very strong methylation component, confirmed by several other studies (ESTELLER 2005; MCLENDON et al. 2008; PHILLIPS 2008) . Also, KEGG pathway enrichment analysis performed on the genes of the ANDnet network identified 4 pathways that are common to both the ANDnet and XORnet network, including cytokine-cytokine receptor interaction, metabolic pathways in cancer, malaria and haematopoietic cell lineage pathways. This suggests that genes in these subsets may display highly complex regulations.
Conclusion
In this work we have described a computational method and integration pipeline based on penalized regression and graph theory: Regression2Net. Using data on genome-wide gene expression and methylation we applied our method in the context of glioblastoma pathology. We biologically validated our findings by means of annotations, pathway enrichment analysis and literature searches. Our integrative analysis pipeline, which includes the construction of XORnet and ANDnet networks, highlighted the added value of network integration prior to functional analysis. We were able to confirm the strong methylation component in glioblastoma pathologies. The evidence provided by our findings, supported by the literature, strongly suggests the potentials of our proposed strategy. 
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